6533b85efe1ef96bd12c0569
RESEARCH PRODUCT
Role of trastuzumab in infracentimetric HER2-positive breast cancer: The southern Italy experience.
Vincenzo AdamoBarbara AdamoCarmelo IaconoGiuseppina Rosaria Rita RicciardiPietro SpadaroHector Soto-parraLivio BlasiG. LaveniaFrancesco VerderameNicolò BorsellinoGiovanni TuccariAngela PrestifilippoAntonio RussoVittorio GebbiaMichele Carusosubject
OncologyGynecologyCancer Researchmedicine.medical_specialtybusiness.industryDiseasemedicine.diseaseBreast cancerOncologyTrastuzumabInternal medicineHER2 Positive Breast Cancermedicineskin and connective tissue diseasesbusinessneoplasmsmedicine.drugdescription
e11512 Background: HER2 positive (HER2+) disease is relatively uncommon in early infracentimetric breast cancer (BC) accounting for approximately 10% of cases. Trastuzumab (T) based-adjuvant therap...
year | journal | country | edition | language |
---|---|---|---|---|
2014-05-20 | Journal of Clinical Oncology |